Verrucarin A inhibition of MAP kinase activation in a PMA-stimulated promyelocytic leukemia cell line

30Citations
Citations of this article
22Readers
Mendeley users who have this article in their library.

Abstract

Verrucarin A is an inhibitor of protein synthesis. In this study, we examined the inhibitory action of verrucarin A on signal molecules. Verrucarin A partially inhibited the IL-8 production of a PMA-stimulated promyelocytic leukemia cell line (HL-60 cells), and the effect was related to the inhibition of NF-κB activation at non-cytotoxic concentrations. Moreover, the inhibition of mitogen activated protein (MAP) kinase by verrucarin A was especially strong with p38- and JNK-phosphorylation. The findings show a new action of verrucarin A, and it is expected that this action relaxes the signal activation in response to stress. © 2005 by MDPI.

Cite

CITATION STYLE

APA

Oda, T., Namikoshi, M., Akano, K., Kobayashi, H., Honma, Y., & Kasahara, T. (2005). Verrucarin A inhibition of MAP kinase activation in a PMA-stimulated promyelocytic leukemia cell line. Marine Drugs, 3(2), 64–73. https://doi.org/10.3390/md302064

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free